# JB Chemicals & Pharmaceuticals Ltd (JBCHEPHARM)
> Exchange: NSE | Sector: Pharma | ISIN: INE572A01036

## Price
Current Price: ₹2228.4
Day Change: +1.63%
52W High: ₹2224.9
52W Low: ₹1603.5
Market Cap: ₹34,337 Cr

## Valuation
P/E: 48.04
P/B: 8.79
EPS: ₹44.52
Book Value: ₹243.37
Dividend Yield: 0.92%

## Returns
1Y Return: 20.18%

## Profitability
ROE: 0%
ROCE: 29.8%
Debt/Equity: 0.01
Revenue Growth: 10.5%
Profit Growth: 21.6%
EBITDA Margin: 27.09%
Operating Margin: 23.52%

## About
JB Chemicals & Pharmaceuticals Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: JB Chemicals & Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-25T20:00:13.927Z
Price History Updated: 2026-05-25T05:29:16.428Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:29:16.428Z
Quant Updated: 2026-05-25T05:29:16.428Z
Sentiment Updated: 2026-05-25T05:29:16.428Z
Financials Status: current
Financials Updated: 2026-05-18T08:30:26.938Z
Financials Last Attempt: 2026-05-18T08:30:26.938Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2016)
Revenue: ₹1144 Cr
Operating Profit: ₹180 Cr (OPM 16%)
Net Profit: ₹100 Cr
Tax: ₹146 Cr

## Annual P&L History
Mar 2016: Rev ₹1144Cr | PAT ₹100Cr | OPM 16%
Mar 2017: Rev ₹1210Cr | PAT ₹163Cr | OPM 17%
Mar 2018: Rev ₹1344Cr | PAT ₹184Cr | OPM 17%

## Balance Sheet (Mar 2016)
Total Assets: ₹1487 Cr
Total Liabilities: ₹1487 Cr
Borrowings: ₹127 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Suresh  Amin, Assistant Vice President – Human Resource
- Kaushal  Solanki CA, Chief Financial Officer
- Bhagwat Singh Deora, Vice President of Finance & Accounts
- Suresh  Bhise, Vice President of Information & Technology
- Sridhar  Bharadwaj, Vice President of Human Resources & Administration

---
Source: rupiya.io/stocks/jbchepharm
Disclaimer: For research and education only. Not investment advice.